Navigation Links
Lo studio EXAMINE della Takeda sulla sicurezza cardiovascolare di alogliptin in aggiunta alla terapia standard ha soddisfatto l'endpoint primario di non inferiorità rispetto al placebo dimostrando che non si verifica nessun incremento del rischio ca
Date:9/17/2013

zza, lo rendono uno studio informativo unico per il trattamento del diabete in alcuni dei pazienti a più alto rischio," ha dichiarato Ajay Ahuja, MD, Vice Presidente, Global Medical Affairs, Takeda. "Nel corso degli ultimi 20 anni, Takeda ha costruito fondamenta solide e mantenuto una elevata attenzione sul diabete. EXAMINE rafforza il nostro impegno scientifico costante sia su alogliptin che nei riguardi della comunità diabetica."

L'endpoint principale secondario di sicurezza è stato costituito da quello composito primario con l'aggiunta del ricovero per angina instabile che ha richiesto una rivascolarizzazione coronarica entro 24 dal ricovero in ospedale. Le valutazioni dell'endpoint secondario composito costituito dalla morte per cause cardiovascolari, infarto del miocardio non fatale, ictus non fatale e angina instabile con rivascolarizzazione urgente, non hanno evidenziato differenze nei tassi di comparsa degli eventi tra alogliptin e placebo (12,7% rispetto al 13,4%; hazard ratio 0,95; limite superiore dell' intervallo di confidenza unilaterale ripetuto, 1,14).

Gli altri endpoint secondari comprendevano la morte per sole cause cardiovascolari e la morte per tutte le cause. La morte per cause cardiovascolari si è verificata in 112 pazienti trattati con alogliptin (4,1%) e in 130 pazienti trattati con placebo (4,9%) per una hazard ratio di 0,85 (limiti di confidenza 95% [CL] dal 0,66 a 1,10, p=0,21). La mortalità per tutte le cause (morti per tutte le cause) si è verificata in 153 pazienti trattati con alogliptin (5,7%) e in 173 pazienti trattati con placebo (6,5%) per una hazard ratio di 0,88 (95% CL da 0,71 a 1,09, p=0,23). Complessivamente, i tassi di morte per tutte le cause e di morte per cause cardiovascolari non hanno evidenziato differenze statisticamente significative tra i gruppi alogliptin e placebo.

Gli endpoint di sicurezza aggiuntivi comprendevano angioedema, ipoglicem
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Anthony Creed Joins DDSTUDIO As GM, Experience Design
2. Daiichi Sankyo ha completato larruolamento dei pazienti per lo studio Hokusai-VTE su Edoxaban, il più ampio trial clinico di fase 3 per il trattamento delle tromboembolie venose ricorrenti
3. Lo studio pubblicato su European Radiology esalta ulteriormente lutilizzo della tomosintesi al seno di Hologic nellambito dello screening del cancro con utilizzo della doppia lettura
4. I benefici della tecnologia Hologic per lutilizzo della Tomosintesi in vengono corroborati dalla pubblicazione di uno studio italiano
5. Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2
6. River City Laser Tattoo Removal Studio Offers Grand Opening Discounts on Treatments Using the Astanza Revolution Laser
7. New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinsons disease
8. New 2012 Cold Chain Report Examines the Extent of Temperature Excursions During the Handling of Temperature-Sensitive Pharmaceutical Shipments
9. Study Examines Smart Pharma Strategies for Effective Messaging around New Products and the Medical Conditions they Treat
10. TeamHealth White Paper Examines Telemedicine Risks, Risk Management Strategies
11. The Food Journal Examines Dietary Supplements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Ala. , Jan. 23, 2015 Gem Pharmaceuticals ... patients have been enrolled into the Company,s Phase 2 ... and safety of Gem,s lead compound, GPX-150 (an investigational ... advanced or metastatic disease. Logo - ...
(Date:1/22/2015)... UPI ), a medical device company that develops, manufactures ... today reported financial results for the fiscal 2015 third ... the Company,s Urgent ®  PC Neuromodulation System grew 14.5% ... compared to $3.9 million in the third quarter of ...
(Date:1/22/2015)... 2015  Profil Institute for Clinical Research, Inc., a clinical ... today a new textbook,  Translational Research Methods for Diabetes, ... leading global scientific publisher. The textbook is ... use in early phase clinical studies of new drugs ...
Breaking Medicine Technology:Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 3Uroplasty Reports Record Revenue in Fiscal Third Quarter 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 5Uroplasty Reports Record Revenue in Fiscal Third Quarter 6Uroplasty Reports Record Revenue in Fiscal Third Quarter 7Uroplasty Reports Record Revenue in Fiscal Third Quarter 8Uroplasty Reports Record Revenue in Fiscal Third Quarter 9Uroplasty Reports Record Revenue in Fiscal Third Quarter 10Uroplasty Reports Record Revenue in Fiscal Third Quarter 11Uroplasty Reports Record Revenue in Fiscal Third Quarter 12Uroplasty Reports Record Revenue in Fiscal Third Quarter 13Uroplasty Reports Record Revenue in Fiscal Third Quarter 14Uroplasty Reports Record Revenue in Fiscal Third Quarter 15Uroplasty Reports Record Revenue in Fiscal Third Quarter 16Uroplasty Reports Record Revenue in Fiscal Third Quarter 17Uroplasty Reports Record Revenue in Fiscal Third Quarter 18New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 2New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 3
... the world,s largest medical device manufacturers, has agreed to ... (DOJ), the Office of the Inspector General for the ... in a qui tam suit related to cardiac rhythm ... pacemakers and implantable cardioverter defibrillators (ICDs). The ...
... the inventor of finger pulse oximetry and a leader ... Personal Finger Pulse Oximeter will be featured on "The ... at 7 a.m. EST and PST; 6 a.m. CST. ... Leonard, Nonin Medical Consumer Products Marketing Manager, is the ...
Cached Medicine Technology:Settlement Announced in Medtronic Qui Tam Case 2Nonin Medical GO2™ Finger Pulse Oximeter to be Featured on "The Balancing Act" TV Show on Lifetime Television 2
(Date:1/22/2015)... Woodloch Pines, an all-inclusive family resort ... as the number one best large hotel for families in ... for their annual Travelers’ Choice Awards. , TripAdvisor represents ... is home to millions of unbiased and honest traveler reviews. ...
(Date:1/22/2015)... 2015 VogueQueen is a seasoned and trusted ... many designers are thrilled to have it lead the wedding ... new collection of prom dresses for the global market. , ... strategic vision and he focuses on continuing the goal of ...
(Date:1/22/2015)... Minn. (PRWEB) January 22, 2015 Blue Cross ... those Minnesotans who exemplify what it means to “Live Fearless.” ... chance for people to share their stories about how they ... or simply inspired others by living in the moment. By ...
(Date:1/22/2015)... 2015 Juvent Sports ( http://www.juventsports.com ) ... PGA Merchandise Show to bestow a Juvent Sports Achievement ... golfer, Arlene McKitrick. The award commemorated and congratulated McKitrick ... win. She won her first amateur tournament in 1979 ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post explaining the ... . , Auto insurance quotes help many drivers find ... necessary to call an agent or visit an agency for ... single website: http://autocarinsurancebest.com/ . , Every business who relies ...
Breaking Medicine News(10 mins):Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Commercial Auto Insurance Provides Several Important Features! 2
... might improve diagnosis, treatment, researchers say , MONDAY, Oct. 5 ... major impact on the diagnosis and treatment of one of ... 231 potential new genes associated with head and neck cancer. ... to head and neck cancer, which includes cancers of the ...
... months when ozone is highest , MONDAY, Oct. 5 (HealthDay ... cardiovascular ills, and now researchers say the dirty air you ... study published in the Oct. 5 issue of the ... go up when the air is dirtier. , "This ...
... ... first time, the American Society of Plastic Surgeons (ASPS) is bringing its popular ... Overview/Webinar for the Media. , ... MEDIA ALERT , ,ATTENTION: MEDICAL/HEALTH, BEAUTY & GROOMING ...
... NEW YORK, Oct. 5 With the school season underway, ... and faculty to please organize blood drives at their schools, ... offers a learning experience for both students and the surrounding ... of Karen Brothers, a middle school educator. Now ...
... GURNEE, Ill., Oct. 5 This year you can wear your ... Chicagoans are expected to turn out in their favorite super ... this year,s Super Jake & Friends Heroes Bash ... in Northbrook, Ill., to benefit The Super Jake Foundation. ...
... Seeks to Encourage Behavior Change and Provide Tools to ... the Workplace and in Schools , WASHINGTON, ... 40 retailers, non-governmental organizations and food and beverage manufacturers ... Weight Commitment Foundation , a national, multi-year effort ...
Cached Medicine News:Health News:Gene Discovery May Advance Head and Neck Cancer Therapy 2Health News:Air Pollution May Cause Appendicitis: Study 2Health News:Air Pollution May Cause Appendicitis: Study 3Health News:Plastic Surgeons to Discuss Cleavage Rejuvenation, Do-It-Yourself Lasers and Other Hot Topics with the Media 2Health News:Blood Drives Offer Lessons in Learning 2Health News:Blood Drives Offer Lessons in Learning 3Health News:Super Jake Foundation Hosts 5th Annual Heroes Bash on Nov. 14 to Benefit Pediatric Cancer Research 2Health News:Retailers, NGOs and Food and Beverage Industry Launch National Initiative to Help Reduce Obesity 2Health News:Retailers, NGOs and Food and Beverage Industry Launch National Initiative to Help Reduce Obesity 3Health News:Retailers, NGOs and Food and Beverage Industry Launch National Initiative to Help Reduce Obesity 4
... AliMed® Turnbuckle Ankle Orthosis enables ... torque at the ankle joint to ... The splint features a pair of ... and eversion/inversion simultaneously. Simply adjust the ...
... the foot and ankle. The internal hind ... plantar flexion (2" high, this may vary ... plantar flexion in 1/8" increments by simply ... the wedge. Ideal for post-surgical or partial ...
Compression Ankle Support Four-way ankle compression support with reinforced triangular closed-heel design for comfort, mobility and longer wear. Reduces swelling and does not retain heat or moisture...
... Ankle Cryo/Cuff combines the therapeutic benefits of ... and cold to minimize pain. The cuff ... ankle providing maximum cryotherapy. The Ankle Cryo/Cuff ... available in a pediatric size.,All Cryo/Cuffs can ...
Medicine Products: